Positron Corp has arranged a line of Credit up to $2 million, with a maximum draw of $500,000 per quarter. This agreement enhances the company's financial flexibility for ongoing projects, supporting its growth strategy.
Key Highlights
- Positron Corp established a line of credit for $2 million with George Ortiz.
- The agreement permits draws of up to $500,000 each quarter and a minimum of $50,000.
- Positron Corp (OTC: POSC) has successfully established a line of credit that allows the company access to up to $2 million, a significant move intended to bolster its financial flexibility.
Positron Corp (OTC: POSC) has successfully established a line of credit that allows the company access to up to $2 million, a significant move intended to bolster its financial flexibility. This strategic financial maneuver is designed to support the company’s operational and growth initiatives.
Credit Line Terms
Initially, for the first year, Positron will focus on servicing interest only, facilitating improved Cash Flow while it capitalizes on the credit line. After the first year, principal repayments will begin, allowing for re-borrowing of previously repaid amounts during the term, subject to established limits. This structured approach provides ample Liquidity to navigate the proposed growth trajectory.
Investor Warrants Included
These warrants will remain valid until December 31, 2030, allowing Ortiz the option to acquire Equity in the firm under favorable terms. Should any default occur on interest payments, the Warrant exercise price adjusts to $1.00 per share, aligning Ortiz's incentives with the company’s long-term financial health.
Implications of Funding Strategy
The current line of credit indicates Positron's commitment to strategic growth and operational enhancement. By providing a flexible financing option, the company intends to allocate resources for the development of its advanced medical imaging technologies. The ability to borrow against previously repaid amounts ensures liquidity remains consistent as the company pursues initiatives geared toward increasing market presence and operational capabilities.
What Comes Next
The next significant date for Positron Corp will be on August 13, 2028, when all borrowed amounts under the line of credit are due. Investors and Stakeholders will be closely observing the company’s financial performance and its ability to manage upcoming principal repayments alongside interest obligations. Continuous monitoring of this funding will be critical as Positron progresses through its growth phases.
Peers Moving on This News
- Envoy Medical, Inc. (NASDAQ: COCH) up 2.8%
- Spectral AI Inc (NASDAQ: MDAI) down 0.3%






Please wait processing your request...